companydata.dkcompanydata.dk

Ambolt Health ApS: Financial statements 2022

CVR: 39662442

Source: annual report 2022, Danish Business Authority

01/01/2022 – 31/12/2022

Ambolt Health ApS (CVR 39662442) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 7,575,875 and a net result of DKK 2,589,933 compared with DKK 253,395 the year before. That is an increase of 174.8% compared with the year before. Equity in the 2022 report amounted to DKK 2,795,474. The solvency ratio was 68.7%. The company had 7 employees in the financial year.

Gross Profit
DKK 7,575,875
Profit/Loss
DKK 2,589,933
Equity
DKK 2,795,474
Total Assets
DKK 4,068,275
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2022-7.6M2.6M2.8M7
2021-2.8M253K206K4
2020--12K-14K-48K0
2019--437-2K-34K0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Keep an eye on Ambolt Health ApS

Get notified instantly about new financial statements, ownership changes, management changes and status changes.

Set up monitoring

Events in 2022

Ambolt Health ApS: The 2021 annual report is outJun 23, 2022

Ambolt Health ApS has published its annual report for 2021. Gross profit came to DKK 2,757,297, and the net result was DKK 253,395.

About Ambolt Health ApS

Ambolt Health ApS is a Danish company of the type Anpartsselskab based in Aalborg, founded in 2018. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named Intmed Danmark ApS and Intmed Danmark IVS. The management consists of Andreas Berre Eriksen and Steen Palle Petersen. The company is owned by Ambolt Holding ApS. The company has 5 employees (2026). In 2025, the company reported a gross profit of DKK 5,309,279 and a net result of DKK 1,900,215 compared with DKK 1,733,386 the year before. Equity in the 2025 report amounted to DKK 2,298,782.

Source: annual report 2025, Danish Business Authority

Other financial years